Year: 2014
Type: article
Abstract: Atomoxetine is a non-stimulant that has no abusive potential and a presynaptic inhibitor of the norepinephrine transporter, and has been found to be a safe and effective treatment for attention deficit/hyperactivity disorder (ADHD) in children, adolescents and adults.1
Source: Evidence-Based Mental Health
Authors: Jaswinder K Ghuman, Shari L Hutchison
Institution: University of Pittsburgh Medical Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1985688739
